Vanguard Group’s Molekule Group, Inc. Common Stock MKUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-497,020
Closed -$72.1K 4585
2023
Q3
$72.1K Buy
497,020
+279,183
+128% +$415K ﹤0.01% 4376
2023
Q2
$510K Buy
217,837
+7,193
+3% +$13.4K ﹤0.01% 4116
2023
Q1
$356K Buy
210,644
+35,943
+21% +$92.9K ﹤0.01% 4210
2022
Q4
$547K Buy
174,701
+60,074
+52% +$199K ﹤0.01% 4073
2022
Q3
$331K Sell
114,627
-35,380
-24% -$214K ﹤0.01% 4326
2022
Q2
$1.97M Buy
+150,007
New +$885K ﹤0.01% 3814

Other funds holding MKUL

Vanguard Group's MKUL Position: Q4 2023 in Review

Vanguard Group sold out of Molekule Group, Inc. Common Stock (MKUL) in Q4 2023, closing a stake of 497,020 shares — an estimated $72.1K sold.

Vanguard Group first reported a position in MKUL in Q2 2022 and held it in 6 quarters. The position peaked at $1.97M in Q2 2022. 3 funds tracked by Wall St. Rank hold MKUL as of Q4 2023.

  • Vanguard Group reported no remaining Molekule Group, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Vanguard Group sold 497,020 Molekule Group, Inc. Common Stock shares in Q4 2023, an estimated $72.1K.
  • Vanguard Group first reported a position in Molekule Group, Inc. Common Stock in Q2 2022 and held it in 6 quarters.
  • Vanguard Group's Molekule Group, Inc. Common Stock position peaked at $1.97M in Q2 2022.
  • 3 funds tracked by Wall St. Rank held Molekule Group, Inc. Common Stock as of Q4 2023.

Based on Vanguard Group's 13F filing for Q4 2023, filed 14 Feb 2024.